SC0191 not checked

Biocity Biopharmaceutics Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“SC0191 PO will be taken on days 1-3, 8-10, and 15-17 of each 28 day cycle.”In the company’s words, NCT06055348 on ClinicalTrials.gov
Tested for
Serous Ovarian Cancer, Advanced Ovarian Cancer
Main trialPhase 1/2
“A phase Ib/II clinical study on the safety, pharmacokinetic characteristics, and preliminary efficacy of SC0191 combination chemotherapy in patients with advanced ovarian cancer.”In the company’s words, NCT06055348 on ClinicalTrials.gov

Other drugs for Advanced Ovarian Cancer

All 265 drugs for Advanced Ovarian Cancer

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Unknown 30 Aug 2025 SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow SC0191

Following is part of Solo: you see every change to SC0191 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in